GIANFILIPPO, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 206
EU - Europa 67
AS - Asia 44
AF - Africa 15
SA - Sud America 2
Totale 334
Nazione #
US - Stati Uniti d'America 202
SE - Svezia 18
SG - Singapore 18
CN - Cina 15
IT - Italia 15
BG - Bulgaria 12
DE - Germania 7
CI - Costa d'Avorio 6
GB - Regno Unito 6
NG - Nigeria 5
VN - Vietnam 4
AT - Austria 3
CA - Canada 3
PL - Polonia 3
SN - Senegal 3
TR - Turchia 3
BR - Brasile 2
HK - Hong Kong 2
IN - India 2
DO - Repubblica Dominicana 1
EG - Egitto 1
FI - Finlandia 1
FR - Francia 1
NL - Olanda 1
Totale 334
Città #
Chandler 37
Fairfield 28
Seattle 19
Ashburn 13
Sofia 12
Santa Clara 10
Singapore 10
New York 8
Cambridge 7
Woodbridge 7
Abidjan 6
Beijing 6
Houston 6
Wilmington 6
Boardman 5
Florence 5
Frankfurt am Main 5
Lagos 5
Lawrence 5
Medford 5
Princeton 5
Ann Arbor 4
Dakar 3
London 3
Vienna 3
Bremen 2
Dong Ket 2
Hong Kong 2
Istanbul 2
Kolkata 2
Ottawa 2
Polska 2
Redwood City 2
Cairo 1
Daly City 1
Denver 1
Diemen 1
Diyarbakir 1
Freitas 1
Fuzhou 1
Helsinki 1
Los Angeles 1
Newton-le-willows 1
Pisa 1
Reston 1
San Francisco 1
Santo Domingo Este 1
Shanghai 1
Shenzhen 1
Silver Spring 1
Toronto 1
Warsaw 1
Totale 258
Nome #
Circulating biomarkers of response to immunotherapy in cancer treatment 77
Erratum: Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers 73
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy 69
Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer 65
Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers 57
Totale 341
Categoria #
all - tutte 1.622
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.622


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202043 0 0 0 0 0 5 10 8 8 2 8 2
2020/202156 0 3 3 5 12 3 11 2 5 2 3 7
2021/202251 2 2 0 2 9 8 2 0 4 5 4 13
2022/2023114 15 17 7 8 15 13 0 7 25 0 7 0
2023/202447 5 4 6 1 6 8 1 3 0 1 7 5
2024/202530 0 5 4 9 12 0 0 0 0 0 0 0
Totale 341